Why are drug prices so high? Investigating th...

Dr. Alicia Zhou is the Chief Executive Officer of the Cancer Research Institute—the oldest nonprofit in the world devoted exclusively to cancer immunology and immunotherapy. She joins Shoshana to discuss the innovations happening in cancer research, how immunotherapy is different ...  Show more

Picture this. You're scrolling late at night and a reel pops up advertising a seemingly magical wellness product with some scientific-sounding marketing language. Do you stick around and maybe even believe it? Or do you scroll away? In this episode, Shoshana explores the mind, an ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...